Cargando…

Germline Mutations for Kidney Volume in ADPKD

INTRODUCTION: Valid prediction models or predictors of disease progression in children and young patients with autosomal dominant polycystic kidney disease (ADPKD) are lacking. Although total kidney volume (TKV) and Mayo imaging classification are generally used to predict disease progression in pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kataoka, Hiroshi, Yoshida, Rie, Iwasa, Naomi, Sato, Masayo, Manabe, Shun, Kawachi, Keiko, Makabe, Shiho, Akihisa, Taro, Ushio, Yusuke, Teraoka, Atsuko, Tsuchiya, Ken, Nitta, Kosaku, Mochizuki, Toshio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897295/ https://www.ncbi.nlm.nih.gov/pubmed/35257066 http://dx.doi.org/10.1016/j.ekir.2021.12.012

Ejemplares similares

Urinary Aquaporin 2 as a Potential Indicator Predicting Tolvaptan Response in Patients With ADPKD
por: Makabe, Shiho, et al.
Publicado: (2021)

Impact of kidney function and kidney volume on intracranial aneurysms in patients with autosomal dominant polycystic kidney disease
por: Kataoka, Hiroshi, et al.
Publicado: (2022)

Prediction of Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease Using PKD1/PKD2 Mutations
por: Kataoka, Hiroshi, et al.
Publicado: (2020)

High Serum Phosphate Level as a Risk Factor to Determine Renal Prognosis in Autosomal Dominant Polycystic Kidney Disease: A Retrospective Study
por: Sato, Masayo, et al.
Publicado: (2020)

Visceral to subcutaneous fat ratio as an indicator of a ≥30% eGFR decline in chronic kidney disease
por: Kataoka, Hiroshi, et al.
Publicado: (2020)

Maximum Carotid Intima-Media Thickness in Association with Renal Outcomes
por: Manabe, Shun, et al.
Publicado: (2021)

Machine learning for morbid glomerular hypertrophy
por: Ushio, Yusuke, et al.
Publicado: (2022)

Sex Differences in Time-Series Changes in Pseudo-R(2) Values Regarding Hyperuricemia in Relation to the Kidney Prognosis
por: Kataoka, Hiroshi, et al.
Publicado: (2020)

Maximum Glomerular Diameter and Oxford MEST-C Score in IgA Nephropathy: The Significance of Time-Series Changes in Pseudo-R(2) Values in Relation to Renal Outcomes
por: Kataoka, Hiroshi, et al.
Publicado: (2019)

Time series changes in pseudo-R(2) values regarding maximum glomerular diameter and the Oxford MEST-C score in patients with IgA nephropathy: A long-term follow-up study
por: Kataoka, Hiroshi, et al.
Publicado: (2020)

Urinary Mulberry Cells as a Biomarker of the Efficacy of Enzyme Replacement Therapy for Fabry Disease
por: Aoyama, Yumi, et al.
Publicado: (2020)

Impacts of Sex Differences in Pulse Pressure among Patients with Chronic Kidney Disease
por: Kataoka, Hiroshi, et al.
Publicado: (2019)

Autosomal Dominant Polycystic Kidney Disease with Emphysematous Polycystic Renal Infection That Required Surgical Treatment
por: Watanabe, Kentaro, et al.
Publicado: (2018)

Successful entecavir plus prednisolone treatment for hepatitis B virus-associated membranoproliferative glomerulonephritis: A case report
por: Kataoka, Hiroshi, et al.
Publicado: (2019)

Glomerular Basement Membrane Protein Expression and the Diagnosis and Prognosis of Autosomal Dominant Alport Syndrome
por: Akihisa, Taro, et al.
Publicado: (2019)

Lupus Nephritis and Hydroxychloroquine-Associated Zebra Bodies: Not Just in Fabry Disease
por: Manabe, Shun, et al.
Publicado: (2021)

PKD1 mutation may epistatically ameliorate nephronophthisis progression in patients with NPHP1 deletion
por: Watanabe, Saki, et al.
Publicado: (2019)

Urate-lowering therapy for CKD patients with asymptomatic hyperuricemia without proteinuria elucidated by attribute-based research in the FEATHER Study
por: Kataoka, Hiroshi, et al.
Publicado: (2022)

Proximal Tubulopathy With Fibrillary Inclusions: A Rare Manifestation of Lymphoma-Associated Monoclonal Gammopathy of Renal Significance (MGRS)
por: Ino, Ayami, et al.
Publicado: (2019)

Cystic Kidney Diseases That Require a Differential Diagnosis from Autosomal Dominant Polycystic Kidney Disease (ADPKD)
por: Sekine, Akinari, et al.
Publicado: (2022)

Comparison of the response of frequently relapsing steroid-dependent minimal change nephrotic syndrome to rituximab therapy between childhood-onset and adult-onset disease
por: Iwabuchi, Yuko, et al.
Publicado: (2018)

Slowly Progressive Male Alport Syndrome Evaluated by Serial Biopsy: Importance of Type IV Collagen Staining
por: Sato, Masayo, et al.
Publicado: (2021)

Hyperuricemia as a Predictive Marker for Progression of Nephrosclerosis: Clinical Assessment of Prognostic Factors in Biopsy-Proven Arterial/Arteriolar Nephrosclerosis
por: Momoki, Kumiko, et al.
Publicado: (2017)

Fibroblast growth factor 23 is upregulated in the kidney in a chronic kidney disease rat model
por: Sugiura, Hidekazu, et al.
Publicado: (2018)

Primary IgA Vasculitis with Nephritis in a Patient with Rheumatoid Arthritis Diagnosed by Anti-galactose-deficient IgA1 Immunostaining
por: Karasawa, Kazunori, et al.
Publicado: (2019)

Heterogeneous Cardiovascular Profiles in CKD: ADPKD Versus non-ADPKD
por: Au, Eric H.K., et al.
Publicado: (2022)

Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease
por: Tsuruta, Yuki, et al.
Publicado: (2014)

Antenatally Diagnosed ADPKD
por: Aldridge, Melanie, et al.
Publicado: (2018)

Intrafamilial Variability of ADPKD
por: Lanktree, Matthew B., et al.
Publicado: (2019)

Serum Hepcidin Levels and Reticulocyte Hemoglobin Concentrations as Indicators of the Iron Status of Peritoneal Dialysis Patients
por: Eguchi, Aya, et al.
Publicado: (2012)

Simultaneous laparoscopic nephrectomy in ADPKD
por: Baishya, Ramen Kumar, et al.
Publicado: (2010)

Polycystins, ADPKD, and Cardiovascular Disease
por: Kuo, Ivana Y., et al.
Publicado: (2019)

Defining Cardiac Dysfunction in ADPKD
por: Kuo, Ivana Y.
Publicado: (2023)

Cardiovascular Manifestations and Management in ADPKD
por: Sagar, Priyanka S., et al.
Publicado: (2023)

A Case of Rapidly Progressive Diabetic Nephropathy Induced by Osimertinib
por: Karasawa, Kazunori, et al.
Publicado: (2023)

The importance of quantifying genetic heterogeneity in ADPKD
por: Chapman, Arlene B.
Publicado: (2014)

Renal Transcatheter Arterial Embolization for ADPKD
por: Oda, Yasuhiro, et al.
Publicado: (2020)

Renal Volume in ADPKD Patient Evaluation
por: Galliani, M., et al.
Publicado: (2020)

The imaging of total kidney volume in ADPKD
por: Cavoli, Gioacchino Li, et al.
Publicado: (2020)

The Impact of COVID-19 on Patients With ADPKD
por: Kutky, Meherzad, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_igk71bcdcq8crhk5cguatild7a